| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Thyroid Hormones | 34 | 2024 | 321 | 5.290 |
Why?
|
| RNA-Binding Proteins | 11 | 2020 | 246 | 3.270 |
Why?
|
| Membrane Transport Proteins | 17 | 2017 | 166 | 3.060 |
Why?
|
| Monocarboxylic Acid Transporters | 25 | 2024 | 79 | 2.930 |
Why?
|
| Triiodothyronine | 26 | 2022 | 339 | 2.710 |
Why?
|
| Thyroid Gland | 13 | 2022 | 270 | 2.380 |
Why?
|
| Selenoproteins | 8 | 2020 | 19 | 2.210 |
Why?
|
| Mutation | 33 | 2023 | 3968 | 2.130 |
Why?
|
| Thyroid Hormone Resistance Syndrome | 13 | 2022 | 116 | 1.930 |
Why?
|
| Symporters | 21 | 2022 | 107 | 1.900 |
Why?
|
| Congenital Hypothyroidism | 12 | 2023 | 79 | 1.840 |
Why?
|
| Iodide Peroxidase | 18 | 2023 | 203 | 1.780 |
Why?
|
| Hyperthyroidism | 5 | 2022 | 75 | 1.720 |
Why?
|
| Muscular Atrophy | 7 | 2024 | 41 | 1.530 |
Why?
|
| Thyroxine | 24 | 2022 | 344 | 1.480 |
Why?
|
| Muscle Hypotonia | 9 | 2024 | 45 | 1.430 |
Why?
|
| Thyroid Hormone Receptors beta | 12 | 2023 | 81 | 1.330 |
Why?
|
| Hypothyroidism | 7 | 2021 | 232 | 1.120 |
Why?
|
| Thyroid Diseases | 8 | 2020 | 104 | 1.100 |
Why?
|
| Thyrotropin | 19 | 2023 | 280 | 1.100 |
Why?
|
| Mental Retardation, X-Linked | 6 | 2024 | 21 | 1.000 |
Why?
|
| Mutation, Missense | 7 | 2020 | 276 | 0.980 |
Why?
|
| Pedigree | 19 | 2020 | 966 | 0.890 |
Why?
|
| Graves Disease | 1 | 2022 | 36 | 0.870 |
Why?
|
| Mice, Knockout | 20 | 2020 | 1924 | 0.820 |
Why?
|
| Zinc | 1 | 2021 | 91 | 0.810 |
Why?
|
| Thyroid Neoplasms | 2 | 2023 | 408 | 0.790 |
Why?
|
| Endocrinology | 1 | 2022 | 66 | 0.790 |
Why?
|
| Selenium | 4 | 2021 | 44 | 0.730 |
Why?
|
| Thyroid Function Tests | 13 | 2021 | 119 | 0.690 |
Why?
|
| Phenotype | 14 | 2021 | 2378 | 0.670 |
Why?
|
| Fusion Regulatory Protein 1, Light Chains | 3 | 2014 | 6 | 0.650 |
Why?
|
| Amino Acid Transport System y+ | 3 | 2014 | 7 | 0.650 |
Why?
|
| Male | 55 | 2022 | 40965 | 0.620 |
Why?
|
| Receptors, Thyroid Hormone | 6 | 2019 | 159 | 0.570 |
Why?
|
| Iron-Binding Proteins | 3 | 2021 | 15 | 0.560 |
Why?
|
| Thyroglobulin | 4 | 2020 | 59 | 0.550 |
Why?
|
| Disease Models, Animal | 6 | 2022 | 2232 | 0.540 |
Why?
|
| Autoantigens | 3 | 2021 | 127 | 0.520 |
Why?
|
| Humans | 70 | 2024 | 86643 | 0.510 |
Why?
|
| Female | 53 | 2023 | 44532 | 0.500 |
Why?
|
| Cell Membrane | 2 | 2013 | 666 | 0.470 |
Why?
|
| Diiodothyronines | 4 | 2015 | 12 | 0.460 |
Why?
|
| Propionates | 4 | 2015 | 34 | 0.460 |
Why?
|
| Cerebral Cortex | 3 | 2014 | 584 | 0.450 |
Why?
|
| Animals | 33 | 2024 | 26582 | 0.450 |
Why?
|
| Heterozygote | 8 | 2021 | 365 | 0.440 |
Why?
|
| Energy Metabolism | 2 | 2015 | 271 | 0.430 |
Why?
|
| Thyroid Dysgenesis | 2 | 2022 | 9 | 0.430 |
Why?
|
| Mice | 23 | 2024 | 11352 | 0.420 |
Why?
|
| Autoimmune Diseases | 2 | 2013 | 241 | 0.410 |
Why?
|
| Adipose Tissue | 1 | 2013 | 240 | 0.400 |
Why?
|
| Child | 16 | 2020 | 6927 | 0.370 |
Why?
|
| Syndrome | 2 | 2010 | 446 | 0.360 |
Why?
|
| Child, Preschool | 15 | 2020 | 3612 | 0.350 |
Why?
|
| Thyrotropin, beta Subunit | 3 | 2020 | 10 | 0.340 |
Why?
|
| Brain | 8 | 2020 | 2216 | 0.330 |
Why?
|
| Mutagenesis, Insertional | 2 | 2020 | 111 | 0.330 |
Why?
|
| Triiodothyronine, Reverse | 3 | 2019 | 32 | 0.330 |
Why?
|
| Placenta | 2 | 2023 | 175 | 0.320 |
Why?
|
| Liver | 7 | 2017 | 1230 | 0.320 |
Why?
|
| Genotype | 10 | 2023 | 1851 | 0.320 |
Why?
|
| Adolescent | 14 | 2021 | 8981 | 0.320 |
Why?
|
| Biological Transport | 6 | 2014 | 396 | 0.310 |
Why?
|
| Homozygote | 5 | 2018 | 200 | 0.310 |
Why?
|
| Antioxidants | 1 | 2009 | 223 | 0.310 |
Why?
|
| Hyperthyroxinemia, Familial Dysalbuminemic | 2 | 2018 | 8 | 0.290 |
Why?
|
| Receptors, Thyrotropin | 3 | 2012 | 47 | 0.280 |
Why?
|
| Genes, erbA | 2 | 2023 | 10 | 0.280 |
Why?
|
| Chorea | 1 | 2005 | 13 | 0.260 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2005 | 34 | 0.260 |
Why?
|
| Pregnancy | 11 | 2023 | 2894 | 0.260 |
Why?
|
| Prenatal Diagnosis | 2 | 2017 | 104 | 0.240 |
Why?
|
| Intellectual Disability | 1 | 2005 | 186 | 0.240 |
Why?
|
| Mice, Inbred C57BL | 10 | 2021 | 3092 | 0.230 |
Why?
|
| Adult | 18 | 2021 | 25648 | 0.230 |
Why?
|
| Diiodotyrosine | 1 | 2023 | 3 | 0.230 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2024 | 104 | 0.220 |
Why?
|
| Antithyroid Agents | 2 | 2020 | 20 | 0.220 |
Why?
|
| Dual Oxidases | 2 | 2020 | 14 | 0.220 |
Why?
|
| Terminology as Topic | 2 | 2014 | 217 | 0.220 |
Why?
|
| Sodium Compounds | 1 | 2021 | 3 | 0.210 |
Why?
|
| Arsenites | 1 | 2021 | 6 | 0.210 |
Why?
|
| Deficiency Diseases | 1 | 2021 | 10 | 0.210 |
Why?
|
| Thyroidectomy | 1 | 2022 | 170 | 0.200 |
Why?
|
| Research | 1 | 2022 | 253 | 0.200 |
Why?
|
| Hormone Replacement Therapy | 1 | 2021 | 77 | 0.200 |
Why?
|
| Cattle | 2 | 2020 | 376 | 0.200 |
Why?
|
| Selenocysteine | 1 | 2020 | 2 | 0.200 |
Why?
|
| Thyroid Hormone Receptors alpha | 1 | 2020 | 22 | 0.190 |
Why?
|
| Fetal Therapies | 1 | 2020 | 5 | 0.190 |
Why?
|
| Propylthiouracil | 1 | 2020 | 24 | 0.190 |
Why?
|
| Prenatal Exposure Delayed Effects | 2 | 2019 | 153 | 0.190 |
Why?
|
| Maternal-Fetal Exchange | 3 | 2017 | 76 | 0.190 |
Why?
|
| Chromogranins | 1 | 2020 | 11 | 0.190 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gs | 1 | 2020 | 19 | 0.180 |
Why?
|
| Alu Elements | 1 | 2020 | 15 | 0.180 |
Why?
|
| Infant | 10 | 2022 | 3046 | 0.180 |
Why?
|
| Dietary Supplements | 2 | 2011 | 128 | 0.180 |
Why?
|
| Animals, Newborn | 4 | 2014 | 510 | 0.180 |
Why?
|
| Drug Therapy, Combination | 1 | 2021 | 894 | 0.170 |
Why?
|
| Fibroblasts | 5 | 2019 | 729 | 0.170 |
Why?
|
| Young Adult | 6 | 2021 | 5976 | 0.170 |
Why?
|
| Insulin Resistance | 1 | 2021 | 377 | 0.170 |
Why?
|
| Protein Multimerization | 1 | 2020 | 173 | 0.170 |
Why?
|
| Serum Albumin, Human | 1 | 2018 | 6 | 0.160 |
Why?
|
| Muscle Weakness | 1 | 2018 | 61 | 0.160 |
Why?
|
| RNA, Messenger | 5 | 2019 | 1981 | 0.160 |
Why?
|
| Serum Albumin | 2 | 2018 | 130 | 0.160 |
Why?
|
| Insulin-Secreting Cells | 1 | 2021 | 397 | 0.150 |
Why?
|
| Fetal Diseases | 2 | 2017 | 81 | 0.150 |
Why?
|
| Double-Blind Method | 1 | 2021 | 1823 | 0.150 |
Why?
|
| Blood Glucose | 1 | 2021 | 873 | 0.150 |
Why?
|
| Islets of Langerhans | 1 | 2020 | 544 | 0.150 |
Why?
|
| Gene Expression Regulation | 4 | 2013 | 1920 | 0.150 |
Why?
|
| Organic Anion Transporters | 2 | 2013 | 27 | 0.150 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2018 | 183 | 0.140 |
Why?
|
| Insulin | 1 | 2021 | 1160 | 0.140 |
Why?
|
| Bone and Bones | 1 | 2017 | 265 | 0.140 |
Why?
|
| Pregnancy Outcome | 1 | 2017 | 247 | 0.140 |
Why?
|
| Sudan | 3 | 2020 | 13 | 0.130 |
Why?
|
| Arabs | 2 | 2012 | 17 | 0.130 |
Why?
|
| DNA-Binding Proteins | 1 | 2021 | 1208 | 0.130 |
Why?
|
| Thyroxine-Binding Globulin | 1 | 2015 | 6 | 0.130 |
Why?
|
| Epigenesis, Genetic | 1 | 2019 | 479 | 0.130 |
Why?
|
| Pregnancy Complications | 1 | 2017 | 336 | 0.120 |
Why?
|
| Muscle, Skeletal | 2 | 2015 | 449 | 0.120 |
Why?
|
| Cerebrum | 1 | 2013 | 15 | 0.120 |
Why?
|
| Adipose Tissue, Brown | 1 | 2013 | 80 | 0.110 |
Why?
|
| Body Composition | 1 | 2013 | 68 | 0.110 |
Why?
|
| Developmental Disabilities | 2 | 2020 | 195 | 0.110 |
Why?
|
| Middle Aged | 7 | 2021 | 25028 | 0.110 |
Why?
|
| Tomography, Optical Coherence | 1 | 2014 | 130 | 0.110 |
Why?
|
| Kinetics | 3 | 2020 | 1513 | 0.110 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2015 | 266 | 0.110 |
Why?
|
| Oxidation-Reduction | 1 | 2013 | 373 | 0.110 |
Why?
|
| Diet | 2 | 2021 | 443 | 0.110 |
Why?
|
| Embryonic Stem Cells | 1 | 2012 | 78 | 0.110 |
Why?
|
| Monitoring, Physiologic | 1 | 2014 | 268 | 0.110 |
Why?
|
| Ventilator-Induced Lung Injury | 1 | 2011 | 31 | 0.100 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2019 | 151 | 0.100 |
Why?
|
| Obesity | 1 | 2018 | 963 | 0.100 |
Why?
|
| Hyperthyroxinemia | 1 | 2011 | 17 | 0.100 |
Why?
|
| Isoenzymes | 2 | 2015 | 271 | 0.100 |
Why?
|
| Retrospective Studies | 2 | 2022 | 8489 | 0.100 |
Why?
|
| Acute Lung Injury | 1 | 2011 | 60 | 0.100 |
Why?
|
| Zebrafish | 1 | 2013 | 309 | 0.100 |
Why?
|
| Phosphatidylinositol 3-Kinase | 1 | 2010 | 14 | 0.100 |
Why?
|
| Family Health | 3 | 2018 | 162 | 0.100 |
Why?
|
| Dependovirus | 2 | 2022 | 33 | 0.090 |
Why?
|
| Signal Transduction | 2 | 2019 | 3241 | 0.090 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2011 | 214 | 0.090 |
Why?
|
| Infant, Newborn | 5 | 2020 | 2379 | 0.090 |
Why?
|
| Molecular Structure | 1 | 2010 | 287 | 0.090 |
Why?
|
| Glycoproteins | 1 | 2010 | 234 | 0.090 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2015 | 879 | 0.080 |
Why?
|
| Blood-Brain Barrier | 1 | 2009 | 70 | 0.080 |
Why?
|
| PAX8 Transcription Factor | 2 | 2022 | 23 | 0.080 |
Why?
|
| Paired Box Transcription Factors | 2 | 2022 | 50 | 0.080 |
Why?
|
| Myopathies, Structural, Congenital | 1 | 2008 | 9 | 0.080 |
Why?
|
| Family | 2 | 2020 | 311 | 0.080 |
Why?
|
| Drug Resistance | 2 | 2006 | 256 | 0.080 |
Why?
|
| Skin | 3 | 2005 | 554 | 0.080 |
Why?
|
| Base Sequence | 4 | 2006 | 2330 | 0.080 |
Why?
|
| Amino Acid Substitution | 2 | 2020 | 339 | 0.080 |
Why?
|
| Transcription Factors | 3 | 2012 | 1565 | 0.080 |
Why?
|
| Alleles | 4 | 2015 | 1128 | 0.080 |
Why?
|
| Pituitary Gland | 1 | 2007 | 117 | 0.080 |
Why?
|
| Feedback, Physiological | 1 | 2007 | 62 | 0.070 |
Why?
|
| Sequence Analysis, DNA | 3 | 2018 | 853 | 0.070 |
Why?
|
| Mosaicism | 1 | 2006 | 67 | 0.070 |
Why?
|
| Cell Differentiation | 1 | 2012 | 1458 | 0.070 |
Why?
|
| Alkaline Phosphatase | 1 | 2006 | 132 | 0.070 |
Why?
|
| Brain Chemistry | 1 | 2006 | 121 | 0.070 |
Why?
|
| Hypothalamus | 1 | 2006 | 79 | 0.070 |
Why?
|
| DNA Mutational Analysis | 3 | 2020 | 526 | 0.070 |
Why?
|
| Diagnosis, Differential | 2 | 2007 | 1565 | 0.070 |
Why?
|
| Lung | 1 | 2011 | 1170 | 0.070 |
Why?
|
| Cell Line | 1 | 2010 | 2468 | 0.070 |
Why?
|
| Response Elements | 1 | 2005 | 63 | 0.070 |
Why?
|
| Siblings | 1 | 2005 | 111 | 0.070 |
Why?
|
| Pituitary Neoplasms | 1 | 2005 | 62 | 0.070 |
Why?
|
| Biomarkers | 2 | 2021 | 1718 | 0.060 |
Why?
|
| Glycolysis | 1 | 2005 | 129 | 0.060 |
Why?
|
| Genetic Association Studies | 2 | 2020 | 294 | 0.060 |
Why?
|
| Nystagmus, Congenital | 1 | 2003 | 2 | 0.060 |
Why?
|
| Cholesterol | 1 | 2006 | 356 | 0.060 |
Why?
|
| Quadriplegia | 1 | 2003 | 22 | 0.060 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2014 | 1373 | 0.060 |
Why?
|
| Point Mutation | 1 | 2004 | 246 | 0.060 |
Why?
|
| Exons | 2 | 2002 | 450 | 0.060 |
Why?
|
| Monoiodotyrosine | 1 | 2023 | 4 | 0.060 |
Why?
|
| Nuclear Proteins | 2 | 2012 | 696 | 0.060 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2020 | 2271 | 0.060 |
Why?
|
| Serogroup | 1 | 2022 | 9 | 0.050 |
Why?
|
| Analysis of Variance | 2 | 2017 | 912 | 0.050 |
Why?
|
| Fetus | 1 | 2023 | 226 | 0.050 |
Why?
|
| Severity of Illness Index | 3 | 2019 | 1801 | 0.050 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2020 | 2357 | 0.050 |
Why?
|
| Thyroxine-Binding Proteins | 1 | 2002 | 86 | 0.050 |
Why?
|
| Central Nervous System Diseases | 1 | 2002 | 52 | 0.050 |
Why?
|
| Insect Proteins | 1 | 2001 | 88 | 0.050 |
Why?
|
| Eye | 1 | 2001 | 111 | 0.050 |
Why?
|
| Haplotypes | 2 | 2015 | 642 | 0.050 |
Why?
|
| Nonsense Mediated mRNA Decay | 1 | 2020 | 4 | 0.050 |
Why?
|
| Early Medical Intervention | 1 | 2020 | 18 | 0.050 |
Why?
|
| Head | 1 | 2001 | 132 | 0.050 |
Why?
|
| Megalencephaly | 1 | 2020 | 21 | 0.050 |
Why?
|
| Amniotic Fluid | 1 | 2020 | 30 | 0.050 |
Why?
|
| Heredity | 1 | 2020 | 19 | 0.050 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 3 | 2010 | 689 | 0.050 |
Why?
|
| Early Diagnosis | 1 | 2020 | 131 | 0.050 |
Why?
|
| Consanguinity | 2 | 2015 | 73 | 0.050 |
Why?
|
| Constipation | 1 | 2020 | 63 | 0.050 |
Why?
|
| Models, Biological | 1 | 2007 | 1749 | 0.050 |
Why?
|
| Substrate Specificity | 1 | 2020 | 347 | 0.040 |
Why?
|
| Primary Cell Culture | 1 | 2019 | 72 | 0.040 |
Why?
|
| Enzyme Activation | 2 | 2011 | 692 | 0.040 |
Why?
|
| Electroencephalography | 1 | 2003 | 709 | 0.040 |
Why?
|
| Risk Assessment | 3 | 2017 | 2261 | 0.040 |
Why?
|
| Protein Domains | 1 | 2020 | 128 | 0.040 |
Why?
|
| Gene Expression | 2 | 2015 | 1284 | 0.040 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2019 | 93 | 0.040 |
Why?
|
| Goiter | 1 | 2018 | 43 | 0.040 |
Why?
|
| Turkey | 1 | 2018 | 20 | 0.040 |
Why?
|
| Cells, Cultured | 3 | 2010 | 2818 | 0.040 |
Why?
|
| Thyroid Nuclear Factor 1 | 2 | 2012 | 12 | 0.040 |
Why?
|
| Gene Expression Regulation, Developmental | 3 | 2010 | 623 | 0.040 |
Why?
|
| Israel | 2 | 2012 | 55 | 0.040 |
Why?
|
| HEK293 Cells | 1 | 2020 | 615 | 0.040 |
Why?
|
| Exome | 1 | 2018 | 127 | 0.040 |
Why?
|
| Australia | 1 | 2018 | 99 | 0.040 |
Why?
|
| Gene Frequency | 1 | 2020 | 677 | 0.040 |
Why?
|
| Follow-Up Studies | 3 | 2017 | 3640 | 0.040 |
Why?
|
| In Vitro Techniques | 1 | 2019 | 989 | 0.040 |
Why?
|
| Placental Circulation | 1 | 2017 | 10 | 0.040 |
Why?
|
| Sampling Studies | 1 | 2017 | 70 | 0.040 |
Why?
|
| Bone Development | 1 | 2017 | 34 | 0.040 |
Why?
|
| Fetal Development | 1 | 2017 | 30 | 0.040 |
Why?
|
| Drosophila | 1 | 2001 | 498 | 0.040 |
Why?
|
| Chondrocytes | 1 | 2017 | 60 | 0.040 |
Why?
|
| Birth Weight | 1 | 2017 | 145 | 0.040 |
Why?
|
| Sex Factors | 1 | 2020 | 1054 | 0.040 |
Why?
|
| Random Allocation | 1 | 2017 | 332 | 0.040 |
Why?
|
| Drosophila Proteins | 1 | 2001 | 488 | 0.040 |
Why?
|
| Mothers | 1 | 2017 | 141 | 0.040 |
Why?
|
| Protein Folding | 1 | 2018 | 282 | 0.030 |
Why?
|
| Prevalence | 1 | 2020 | 1239 | 0.030 |
Why?
|
| Glycerol-3-Phosphate Dehydrogenase (NAD+) | 1 | 2015 | 3 | 0.030 |
Why?
|
| Amino Acid Sequence | 3 | 2007 | 2062 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2020 | 1805 | 0.030 |
Why?
|
| Drinking | 1 | 2015 | 34 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 2 | 2015 | 1376 | 0.030 |
Why?
|
| Pakistan | 1 | 2015 | 15 | 0.030 |
Why?
|
| Injections, Intraperitoneal | 1 | 2015 | 102 | 0.030 |
Why?
|
| Glutathione Transferase | 1 | 2015 | 111 | 0.030 |
Why?
|
| Glycine | 1 | 2015 | 92 | 0.030 |
Why?
|
| Arginine | 1 | 2015 | 136 | 0.030 |
Why?
|
| Eating | 1 | 2015 | 166 | 0.030 |
Why?
|
| Genetic Therapy | 1 | 2016 | 342 | 0.030 |
Why?
|
| Tissue Distribution | 1 | 2014 | 290 | 0.030 |
Why?
|
| Embryo, Mammalian | 1 | 2014 | 207 | 0.030 |
Why?
|
| Amino Acid Transport System y+L | 1 | 2013 | 3 | 0.030 |
Why?
|
| Organic Anion Transporters, Sodium-Independent | 1 | 2013 | 5 | 0.030 |
Why?
|
| Canada | 1 | 2014 | 204 | 0.030 |
Why?
|
| Organic Cation Transport Proteins | 1 | 2013 | 13 | 0.030 |
Why?
|
| COS Cells | 2 | 2004 | 166 | 0.030 |
Why?
|
| Bangladesh | 1 | 2014 | 318 | 0.030 |
Why?
|
| Compassionate Use Trials | 1 | 2012 | 8 | 0.030 |
Why?
|
| Hemoglobins | 1 | 1993 | 179 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2020 | 3362 | 0.030 |
Why?
|
| Age Factors | 1 | 2017 | 1851 | 0.030 |
Why?
|
| Diseases in Twins | 1 | 2012 | 65 | 0.030 |
Why?
|
| Amino Acids | 1 | 1993 | 252 | 0.030 |
Why?
|
| Protein Conformation | 1 | 2015 | 881 | 0.030 |
Why?
|
| Multicenter Studies as Topic | 1 | 2012 | 159 | 0.030 |
Why?
|
| Cardiotonic Agents | 1 | 2012 | 87 | 0.030 |
Why?
|
| Mice, 129 Strain | 1 | 2011 | 55 | 0.030 |
Why?
|
| Mice, Inbred DBA | 1 | 2011 | 148 | 0.030 |
Why?
|
| Founder Effect | 1 | 2012 | 104 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 2 | 2007 | 937 | 0.030 |
Why?
|
| Chemokines | 1 | 2011 | 73 | 0.030 |
Why?
|
| Mice, Inbred Strains | 1 | 2011 | 307 | 0.020 |
Why?
|
| Mice, Inbred C3H | 1 | 2011 | 370 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2015 | 1286 | 0.020 |
Why?
|
| Child Development | 1 | 2012 | 163 | 0.020 |
Why?
|
| Methimazole | 1 | 2010 | 13 | 0.020 |
Why?
|
| Mutant Proteins | 1 | 2010 | 94 | 0.020 |
Why?
|
| Crosses, Genetic | 1 | 2010 | 171 | 0.020 |
Why?
|
| Hormones | 1 | 2010 | 141 | 0.020 |
Why?
|
| Species Specificity | 1 | 2011 | 678 | 0.020 |
Why?
|
| Prognosis | 1 | 2017 | 3679 | 0.020 |
Why?
|
| Transcriptional Activation | 1 | 2010 | 280 | 0.020 |
Why?
|
| Neurogranin | 1 | 2009 | 3 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2011 | 1047 | 0.020 |
Why?
|
| Psychomotor Performance | 1 | 2012 | 492 | 0.020 |
Why?
|
| DNA | 2 | 2006 | 1294 | 0.020 |
Why?
|
| Protein Biosynthesis | 1 | 2010 | 378 | 0.020 |
Why?
|
| Rats, Inbred Dahl | 1 | 2007 | 8 | 0.020 |
Why?
|
| Rats, Inbred BN | 1 | 2007 | 37 | 0.020 |
Why?
|
| Cytokines | 1 | 2011 | 776 | 0.020 |
Why?
|
| Osmolar Concentration | 1 | 2007 | 181 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2011 | 1753 | 0.020 |
Why?
|
| Chromosomes | 1 | 2007 | 96 | 0.020 |
Why?
|
| Animals, Genetically Modified | 1 | 2007 | 181 | 0.020 |
Why?
|
| Introns | 1 | 2007 | 289 | 0.020 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 2006 | 147 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2010 | 1961 | 0.020 |
Why?
|
| Phosphofructokinase-1, Type C | 1 | 2005 | 2 | 0.020 |
Why?
|
| Glucose Transporter Type 4 | 1 | 2005 | 17 | 0.020 |
Why?
|
| Chromones | 1 | 2005 | 28 | 0.020 |
Why?
|
| Lymphocytes | 1 | 1988 | 464 | 0.020 |
Why?
|
| Leukemia | 1 | 1988 | 320 | 0.020 |
Why?
|
| Morpholines | 1 | 2005 | 65 | 0.020 |
Why?
|
| Cytosol | 1 | 2005 | 189 | 0.020 |
Why?
|
| gamma-Globulins | 1 | 1984 | 16 | 0.020 |
Why?
|
| Skin Physiological Phenomena | 1 | 2004 | 27 | 0.020 |
Why?
|
| Dimerization | 1 | 2004 | 143 | 0.020 |
Why?
|
| Immunization, Passive | 1 | 1984 | 71 | 0.020 |
Why?
|
| Muscle Proteins | 1 | 2005 | 132 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2010 | 1384 | 0.020 |
Why?
|
| Chromosome Mapping | 1 | 2007 | 1074 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2006 | 927 | 0.020 |
Why?
|
| DNA, Complementary | 1 | 2004 | 393 | 0.010 |
Why?
|
| Communicable Diseases | 1 | 1984 | 63 | 0.010 |
Why?
|
| Nucleic Acid Conformation | 1 | 2004 | 332 | 0.010 |
Why?
|
| Threonine | 1 | 2003 | 33 | 0.010 |
Why?
|
| Proline | 1 | 2003 | 57 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2005 | 639 | 0.010 |
Why?
|
| Chromosome Segregation | 1 | 2002 | 32 | 0.010 |
Why?
|
| Ectoderm | 1 | 2001 | 29 | 0.010 |
Why?
|
| RNA Splice Sites | 1 | 2002 | 53 | 0.010 |
Why?
|
| Hedgehog Proteins | 1 | 2001 | 93 | 0.010 |
Why?
|
| Vertebrates | 1 | 2001 | 90 | 0.010 |
Why?
|
| Genes, Insect | 1 | 2001 | 183 | 0.010 |
Why?
|
| Rats | 1 | 2007 | 3990 | 0.010 |
Why?
|
| Biopsy | 1 | 2004 | 1163 | 0.010 |
Why?
|
| RNA | 1 | 2004 | 560 | 0.010 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2004 | 384 | 0.010 |
Why?
|
| Neurons | 1 | 2009 | 1546 | 0.010 |
Why?
|
| Romania | 2 | 1993 | 4 | 0.010 |
Why?
|
| Body Patterning | 1 | 2001 | 209 | 0.010 |
Why?
|
| Lung Diseases | 1 | 2002 | 263 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2004 | 2426 | 0.010 |
Why?
|
| Repressor Proteins | 1 | 2001 | 403 | 0.010 |
Why?
|
| Liver Neoplasms | 1 | 2004 | 736 | 0.010 |
Why?
|
| Periodontal Diseases | 1 | 1978 | 9 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 2002 | 819 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2002 | 3030 | 0.010 |
Why?
|
| Amino Acid Metabolism, Inborn Errors | 1 | 1993 | 11 | 0.010 |
Why?
|
| Trace Elements | 1 | 1993 | 11 | 0.010 |
Why?
|
| Minerals | 1 | 1993 | 22 | 0.010 |
Why?
|
| Organic Chemicals | 1 | 1993 | 33 | 0.010 |
Why?
|
| Drug Combinations | 1 | 1993 | 224 | 0.010 |
Why?
|
| Vitamins | 1 | 1993 | 81 | 0.010 |
Why?
|
| Anesthesia, Obstetrical | 1 | 1971 | 25 | 0.010 |
Why?
|
| Acid-Base Equilibrium | 1 | 1971 | 32 | 0.010 |
Why?
|
| Rosette Formation | 1 | 1988 | 34 | 0.010 |
Why?
|
| Fluorescent Antibody Technique | 1 | 1988 | 316 | 0.000 |
Why?
|
| Acute Disease | 1 | 1988 | 826 | 0.000 |
Why?
|
| Hematopoietic Stem Cells | 1 | 1988 | 292 | 0.000 |
Why?
|
| Infusions, Parenteral | 1 | 1984 | 50 | 0.000 |
Why?
|
| Drug Tolerance | 1 | 1984 | 63 | 0.000 |
Why?
|
| Time Factors | 1 | 1993 | 5210 | 0.000 |
Why?
|
| Clinical Trials as Topic | 1 | 1984 | 1169 | 0.000 |
Why?
|
| Aged | 2 | 1988 | 18415 | 0.000 |
Why?
|
| Gingiva | 1 | 1978 | 8 | 0.000 |
Why?
|
| Mouth Mucosa | 1 | 1978 | 67 | 0.000 |
Why?
|
| Autoantibodies | 1 | 1978 | 267 | 0.000 |
Why?
|
| Acidosis | 1 | 1971 | 55 | 0.000 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1971 | 493 | 0.000 |
Why?
|